Next Article in Journal
Exploring the Chemical Profile, In Vitro Antioxidant and Anti-Inflammatory Activities of Santolina rosmarinifolia Extracts
Previous Article in Journal
Lattice Model Results for Pattern Formation in a Mixture with Competing Interactions
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 29
Issue 7
10.3390/molecules29071513
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

A Paternò–Büchi Reaction of Aromatics with Quinones under Visible Light Irradiation

by
Wen-Wen Li
†,
Jia-Lin Zhao
†,
Ze-Yu Wang
,
Pei-Ting Li
,
Zi-Fa Shi
*,
Xiao-Ping Cao
and
Qiang Liu
*
State Key Laboratory of Applied Organic Chemistry and College of Chemistry & Chemical Engineering, Lanzhou University, Lanzhou 730000, China
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Molecules 2024, 29(7), 1513; https://doi.org/10.3390/molecules29071513
Submission received: 22 February 2024 / Revised: 21 March 2024 / Accepted: 25 March 2024 / Published: 28 March 2024
(This article belongs to the Section Organic Chemistry)
Browse Figures
Versions Notes

Abstract

:
Reported herein is a Paternò–Büchi reaction of aromatic double bonds with quinones under visible light irradiation. The reactions of aromatics with quinones exposed to blue LED irradiation yielded oxetanes at −78 °C, which was attributed to both the activation of double bonds in aromatics and the stabilization of oxetanes by thiadiazole, oxadiazole, or selenadiazole groups. The addition of Cu(OTf)2 to the reaction system at room temperature resulted in the formation of diaryl ethers via the copper-catalyzed ring opening of oxetanes in situ. Notably, the substrate scope was extended to general aromatics.

Graphical Abstract

1. Introduction

Oxetane structural units are widely present in natural products and pharmaceutical active molecules [1,2,3,4,5]. The Paternò–Büchi (PB) reaction is an effective method to synthesize azetidines [6,7,8,9] and oxetanes [10,11,12,13]. The PB reaction originally referred to the reaction of olefins and carbonyl compounds under light irradiation to synthesize oxetanes (Scheme 1a) [14,15]. After decades of development, several carbon–carbon double bonds were subjected to the PB reaction with carbonyl compounds to synthesize oxetanes. Alkynes and carbonyl compounds yield unsaturated carbonyl compounds via oxetane intermediates (Scheme 1b) [16]. Furans [17,18], thiophenes [19,20,21], pyrroles [22,23], imidazoles [24,25], oxazoles [26], and indoles [27] also underwent the PB reaction with carbonyl under light conditions to generate oxetanes (Scheme 1c). The higher delocalization of large π-systems in the benzene ring than in the aromatic heterocyclic ring hinders addition reactions of aromatics, although they can be functionalized by radicals to synthesize phenols or arylamines [28,29]. To our knowledge, the PB reaction involving aromatic double bonds has not yet been reported, which facilitates the construction of oxa-[4.2.0] skeletons.
The vast majority of PB reactions require the use of UV light. A few visible-light PB reactions have recently been reported. In 2019, functionalized azetidines were synthesized via intramolecular aza PB reactions between imines and alkenes under visible light irradiation catalyzed by precious Ir-based complexes, as reported by Schindler and coworkers [30]. In 2020, Dell’Amico and coworkers developed a visible-light PB reaction of substituted indoles and aromatic ketones [27].
Herein, a PB reaction of aromatics with quinones was developed under visible light irradiation. At −78 °C, the [2+2] cycloadditions of carbon–carbon double bonds in the aromatics, which were activated by thiadiazole, oxadiazole, or selenadiazole, were achieved to form oxetanes with the carbonyl of quinones under blue LED irradiation (λ = 450 nm). The addition of Cu(OTf)2 at room temperature resulted in the synthesis of diaryl ethers from aromatics and quinones under the same irradiation via an oxetane intermediate. The range of substrate adaptation can be extended to general aromatics for the synthesis of diaryl ethers.

2. Results

Initially, 5,6-dimethylbenzothiadiazole (1a) and p-benzoquinone (2a) were selected as the model substrates. The solution of 1a and 2a with equivalent doses in CH3CN at 40 °C under blue LED (450 nm, 5 W) resulted in a 25% yield of oxetane 3a (Table 1, entry 1). The ratio of 1a and 2a affected the yield of 3a (Table 1, entries 2–4). A 3:1 ratio of 1a and 2a increased the yield of 3a to 43% (Table 1, entry 4). Irradiation with UV light (λ = 254 nm) resulted in only a 7% yield of 3a. Energy transfer catalysts can be used to promote [2+2] photocycloaddition [31]. The sensitizers matching the triplet excitation energy of 1a (ET = 46.1 kcal mol−1, calculated by DFT under B3LYP/6-31G(d)) or 2a (ET = 53.6 kcal mol−1) were used to improve the reaction yield, such as Ir(ppy)3 (ET = 58.1 kcal mol−1), Ru(bpy)3Cl2·6H2O (ET = 49.0 kcal mol−1), and thioxanthen-9-one (ET = 63.4 kcal mol−1) [32]; however, they did not contribute to this reaction (Table 1, entries 6–8). Because product 3a can be partially decomposed into starting materials during separation, the reaction was carried out at low temperatures to increase the yield. When the reaction was performed at –40 °C, the yield was increased to 48% (entry 9). At –78 °C, no oxetane 3a was detected when Et2O or THF was used as a solvent (Table 1, entries 10 and 11). In dichloromethane (DCM), the optimal yield of 3a was 74%. And, when the reaction was carried out in the dark at –78 °C, there was no 3a detected. Thus, the use of 1a (0.9 mmol) and 2a (0.3 mmol) in DCM (3 mL) at –78 °C under blue LED irradiations represents optimized reaction conditions.
Under the optimized reaction conditions, the substituent effect was significant and similar to many reported PB reactions [10]. The presence of methyl groups in 1 at position 5 or 6 facilitated the formation of oxetane products under the optimized conditions. As X in 1 was selenium or oxygen, oxetanes 3b and 3c were formed in 64% and 43% yields, respectively (Scheme 2). The presence of only a single methyl in 5-methylbenzo[c][1,2,5]thiadiazole (1d) at position 5 resulted in the selective synthesis of compound 3d in 38% yield. The PB reaction only involved the double bonds with the methyl group in 1d. The substrate 2-methylcyclohexa-2,5-diene-1,4-dione (2b) was also used in the PB reactions involving 1a, 5,6-dimethylbenzo[c][1,2,5]selenadiazole (1b), or 5,6-dimethylbenzo[c][1,2,5]oxadiazole (1c) to synthesize oxetanes. Only the carbonyl at position 4 in 2b participated in the PB reaction. The two isomers (3e and 3e′, 3f and 3f′), whose configurations (3e and 3e′) were confirmed via NOESY spectra (pages S16 and S18 in Supplementary Materials), were formed via the reaction of 2b with 1a and 1b, respectively. However, only isomer 3g was detected in the reaction between 2b and 1c. Naphthalene-1,4-dione (1e) was also used as a substrate in this PB reaction to obtain oxetane 3h in 8% yield.
At room temperature, the oxetane products in solution can be translated into the starting materials, e.g., a portion of 3a was transformed into 1a and 2a in deuterated chloroform in 2 h. Thus, an equilibrium may exist between the oxetane products and the starting materials in the reactions under the optimized reaction conditions. In the case of the other substrates, the equilibrium shifted in favor of the starting materials, resulting in a low yield of oxetanes, which could not be separated. To expand the application of this reaction, Cu(OTf)2 was added to translate the oxetane to shift the equilibrium to the right by the ring-opening reaction of the oxetane catalyzed by Lewis acid [33,34]. Compound 4a was obtained when the reaction of 1a, 2a, and Cu(OTf)2 (0.1 equiv.) in CH3CN was carried out under blue LED irradiation, which prompted us to develop a method for the synthesis of diaryl ethers (Scheme 3).
Diaryl ethers are important structural units, which are widely present in natural product molecules and functional materials [35,36]. Therefore, the development of effective methods for synthesizing diaryl ether has great research significance and widespread application. The general method to produce diaryl ethers involves the reaction of aryl halides with phenoxides via substitution reactions at high temperature in the presence of electron-withdrawing groups in aryl halides [37,38], and with phenols or phenoxides via transition metal-catalyzed reactions [39,40,41]. Methods for the synthesis of diaryl ethers also were developed without the use of aryl halides. The reactions involving phenols with aryl boronic acids in the presence of copper acetate were developed to synthesize diaryl ethers [42,43,44,45]. Recently, Ritter and coworkers developed a two-step process of diaryl ether synthesis from electron-rich aromatics and phenols using aryl thianthrenium salts by photoredox chemistry [46]. In this work, diaryl ethers were synthesized via a reaction between quinones and aromatics, which included electron-rich, -poor, and -neutral aromatics under blue LED in the presence of Cu(OTf)2.
To ensure optimized conditions, benzo[c][1,2,5]thiadiazole (1b) was used as the model substrate in the reaction with 2a for conditional screening (Table 2). To our delight, the diaryl ether product 4b was afforded in 50% yield using Cu(OTf)2 (10% of 2a) as the catalyst in CH3CN at 40 °C under blue LED for 48 h (entry 1). Photosensitizers (Ir(bpy)3, Ru(bpy)3Cl2·6H2O, and thioxanthen-9-one) were also added to the reactions to increase the product yield, but there was no effect on the yield increase in 4a (entries 2–4). The Lewis acids were selected as catalysts to optimize this reaction. When the Lewis acids, Fe(OTf)3, Zn(OTf)2, Yb(OTf)3, Nd(OTf)3, and Sc(OTf)3 (entries 5–9), were used to replace Cu(OTf)2 in the reactions, product 4a could be obtained, but the yields were lower than that of entry 1. The using of Pd(OAc)2, AgOAc, and BF3·Et2O did not give 4a. The product yield was also affected by reaction temperature. When the reaction was carried out at 25 °C, the yield of 4a was increased to 53% (entry 13). The decrease in the ratio of 1b and 2a did not increase the yield of 4a (entries 15–18). Under the 3:1 ratio of 1b and 2a, the yield of 4a increased to 65% when the amount of Cu(OTf)2 increased to 20% of 2a (entry 19). Then, the solvent effect was explored to increase the product yield. Product 4a was not detected when the reactions were carried out in CH3OH, acetone, Et2O, or THF (entries 20–23). When DCM was used as a solvent, 4a was obtained in 45% yield. Thus, a mixed solvent of DCM and CH3CN was used in the reaction, which resulted in the highest yield of 4a (67%, entry 25). In addition, without blue LED irradiation, no 4a was obtained (entry 26), which indicated that the excitation of the starting material was a decisive factor in the reaction rather than the copper-catalyzed coupling reaction. Finally, after the optimization of Lewis acids, reaction temperature, and solvents, 1b (0.9 mmol), 2a (0.3 mmol), and Cu(OTf)2 (0.06 mmol) in CH3CN/DCM (1:1, 3 mL) at room temperature for 48 h under blue LED were determined as the optimized conditions.
We then explored the scope of diaryl ether synthesis (Scheme 4). As substrate 1 contains thiadiazole, etherification always occurs at the active positions 4 or 7 in 1. Under the optimized conditions, 4b was obtained in 67% yield. The introduction of the same functional groups at positions 5 and 6 in 1, such as CH3, F, Cl, and Br, resulted in diaryl ethers 4a and 4c–4e in good yield (besides 4c). In the presence of a single substituent group in benzothiadiazole, the regioselectivity of the etherification was controlled by the electronic effects of the substituent. The presence of an electron-rich group (CH3, CH3O) at position 5 of 1 resulted in the synthesis of compounds 4f and 4g in 67% and 55% yield, respectively, via etherification at position 4 of 1. With halogen at position 5 in 1, two isomers of etherification at positions 4 and 7 were obtained, but the main products were 4h, 4i, and 4j. When position 5 of 1 was substituted by the formyl group (electron-poor group), its etherification at position 4 produced 4k in 49% yield. The presence of a CH3 group at position 4 in 1 led to its etherification at position 7 to generate 4l in 58% yield. The reaction of 6-methylbenzo[c][1,2,5]thiadiazole-5-carbaldehyde (1m, R1 = 5-CHO, R2 = 6-CH3) and 2a afforded 4m in low yield. However, 5-bromo-6-methylbenzo[c][1,2,5]thiadiazole (1n, R1 = 5-Br, R2 = 6-CH3) reacted smoothly with 2a under standard conditions to generate two isomers 4n and 4n’ in good yields. General aromatics without the activating group (thiadiazole) were also used in this reaction to afford the corresponding diaryl ethers. Benzene as a substrate reacted with benzoquinone under standard conditions to yield 4o (46%). Reducing the reaction temperature to −40 °C resulted in a 95% yield of 4o (Table S1). The synthesis of 4p, 4q, 4s, and 4u was carried out in the presence of Cu(OTf)2 in CH3CN/DCM (1:1) at −40 °C for 48 h. When methyl 2,4,6-trimethylbenzoate was used as the substrate, the corresponding product 4p was obtained in 64% yield, although it had steric hindrance. Etherification at the α position of naphthalene afforded 4q in 87% yield. The substituent quinones also were tolerated in this reaction. The reactions of 2,3-dimethylbenzoquinone (2c, R3 = 2,3-dimethyl) with 1b and benzene were carried out to obtain 4r and 4s with a yield of 34% and 44%, respectively. 2-Chlorobenzoquinone (2d, R3 = 2-Cl) reacted with 1b to afford 4t in 24% yield but with benzene to yield 4u in good yield (89%).
The products all were characterized by 1H NMR, 13C NMR, and HRMS. The configurations of products were confirmed by X-ray analysis of the single crystals of 3a, 4b, 4k, 4n, and 4t.
To elucidate the reaction mechanisms, the control experiments, UV-vis absorption, and fluorescence involved 1a and 2a were investigated. In UV-vis absorption spectra (Figure S1), only benzoquinone (2a) had an absorption peak at >400 nm, which was not affected by 1a or Cu(OTf)2. As shown in Scheme 5, no products were detected when 2,2,6,6-tetramethylpiperidinooxy (TEMPO) was added to the reactions during the synthesis of oxetane 3a and diaryl ether 4a under standard conditions (I and II in Scheme 5). The results showed that 2a was excited under blue LED and the processes involved free radicals. Product 3a could be smoothly obtained in the reaction with triplet quencher DABCO (III in Scheme 5), or the reaction under atmosphere (IV in Scheme 5) [47], which indicated that the triplet state was not favored in the reaction system. The result of the energy transfer calculations from the Gibbs energy of the photoinduced electron transfer (PET) equation showed ΔG > 0 (page S51 in Supplementary Materials), forbidding the possibility of the PET mechanism, which also needs to involve the triplet state [47]. Oxetane 3a was treated with Cu(OTf)2 (0.2 equiv.) in DCM/CH3CN (1:1) at room temperature to obtain compound 5, whose structure was confirmed via X-ray analysis of its single crystal (V in Scheme 5).
Based on the literature [13,48] and the experimental evidence, a plausible mechanism of the reactions involving 1a and 2a was proposed (Scheme 6). Under blue LED irradiation, 2a was excited to the singlet state and reacted with 1a to mainly form the singlet exciplex (A) [49]. The two oxetane products (3a and 3a′) may be produced via singlet biradical intermediates, which could go back to 1a and 2a. Oxetane 3a was more stable than 3a′ (the internal energy difference was 8 kcal/mol, which was calculated by DFT at the B3LYP/6-31G* level), which can be separated and characterized. Treatment of 3a with Cu(OTf)2 resulted in the cleavage of the carbon–carbon bond in oxetane to form intermediate C, followed by methyl migration and aromatization resulting in 5. When the starting materials were treated with Cu(OTf)2 under blue LED irradiation at room temperature, the equilibrium was biased toward raw materials. However, the highly reactive intermediate 3a′ was transformed into intermediate E, followed by aromatization to form 4a, which eventually promoted the transformation of starting materials to 4a. Accordingly, only 4a was obtained instead of 5 because of the high energy barrier from C to D.

3. Experimental Section

3.1. Synthetic Procedures

3.1.1. General Process I: Synthesis of Oxetanes (3a–3h)

To a quartz tube containing a stirring bar, aromatic 1 (0.9 mmol), quinone 2 (0.3 mmol), and dichloromethane (3 mL) were added. The reaction tube was degassed with argon and stirred for 48 h at –78 °C under blue LED (λ = 450 nm, 5 W) irradiation. The reaction system was raised to room temperature and transferred into a single-necked flask. The reaction mixture was concentrated in vacuo and separated by column chromatography (PE/EtOAc = 5:1) to obtain 3.
  • 5′,5a′-Dimethyl-5a′,7a′-dihydrospiro[cyclohexane-1,7′-oxeto[3′,2′:3,4]benzo[1,2-c][1,2,5]thiadiazole]-2,5-dien-4-one (3a). Colorless solid (61 mg, 74%); M.p. 108–110 °C; 1H NMR (600 MHz, CDCl3) δ 7.16 (dd, J = 10.1 Hz, 3.0 Hz, 1H), 6.84 (dd, J = 10.2 Hz, 2.9 Hz, 1H), 6.64 (s, 1H), 6.21 (d, J = 10.0 Hz, 1H), 5.98 (d, J = 10.3 Hz, 1H), 4.44 (s, 1H), 2.06 (s, 3H), 1.84 (d, J = 0.7 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 184.2 (C), 155.7 (C), 153.5 (C), 147.7 (CH), 146.7 (C), 144.6 (CH), 129.7 (CH), 128.4 (CH), 118.3 (CH), 82.6 (C), 78.8 (C), 50.6 (CH), 28.8 (CH3), 16.6 (CH3); HRMS (ESI) m/z calcd for C14H13N2O2S [M + H]+: 273.0692, found: 273.0694.
  • 5′,5a′-Dimethyl-5a′,7a′-dihydrospiro[cyclohexane-1,7′-oxeto[3′,2′:3,4]benzo[1,2-c][1,2,5]selenadiazole]-2,5-dien-4-one (3b). Colorless solid (61 mg, 64%); M.p. 107–109 °C; 1H NMR (400 MHz, CDCl3) δ 7.15 (dd, J = 10.0 Hz, 3.2 Hz, 1H), 6.84 (dd, J = 10.0 Hz, 3.2 Hz, 1H), 6.65 (d, J = 1.6 Hz, 1H), 6.20 (dd, J = 10.0 Hz, 2.0 Hz, 1H), 5.97 (dd, J = 10.4 Hz, 2.0 Hz, 1H), 4.43 (s, 1H), 2.04 (d, J = 1.6 Hz, 3H), 1.82 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 184.4 (C), 159.7 (C), 158.4 (C), 148.0 (CH), 147.3 (C), 144.7 (CH), 130.0 (CH), 128.7 (CH), 122.0 (CH), 82.8 (C), 78.7 (C), 53.7 (CH), 28.7 (CH3), 16.7 (CH3); HRMS (ESI) m/z calcd for C14H13N2O2Se [M + H]+: 321.0137, found: 321.0135.
  • 5′,5a′-Dimethyl-5a′,7a′-dihydrospiro[cyclohexane-1,7′-oxeto[3′,2′:3,4]benzo[1,2-c][1,2,5]oxadiazole]-2,5-dien-4-one (3c). Colorless solid (33 mg, 43%); M.p. 113–115 °C; 1H NMR (400 MHz, CDCl3) δ 7.15 (dd, J = 10.1 Hz, 2.8 Hz, 1H), 6.75 (dd, J = 10.4 Hz, 3.2 Hz, 1H), 6.62 (d, J = 1.6 Hz, 1H), 6.21 (dd, J = 10.2 Hz, 2.0 Hz, 1H), 6.05 (dd, J = 10.0 Hz, 2.0 Hz, 1H), 4.46 (s, 1H), 2.07 (d, J = 1.6 Hz, 3H), 1.81 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 184.0 (C), 149.8 (C), 148.8 (C), 147.1 (CH), 146.9 (C), 143.6 (CH), 130.4 (CH), 129.1 (CH), 110.4 (CH), 81.1 (C), 77.6 (C), 44.4 (CH), 28.5 (CH3), 17.2 (CH3); HRMS (ESI) m/z calcd for C14H13N2O3 [M + H]+: 257.0921, found: 257.0920.
  • 5a′-Methyl-5a′,7a′-dihydrospiro[cyclohexane-1,7′-oxeto[3′,2′:3,4]benzo[1,2-c][1,2,5]thiadiazole]-2,5-dien-4-one (3d). Light-yellow liquid (30 mg, 38%); 1H NMR (400 MHz, CDCl3) δ 7.18 (dd, J = 10.0 Hz, 3.2 Hz, 1H), 6.87 (d, J = 10.0 Hz, 1H), 6.76 (dd, J = 10.0 Hz, 2.8 Hz, 1H), 6.29 (d, J = 10.0 Hz, 1H), 6.20 (dd, J = 10.0 Hz, 2.0 Hz, 1H), 5.97 (dd, J = 10.4 Hz, 2.0 Hz, 1H), 4.46 (s, 1H), 1.80 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 184.3 (C), 154.8 (C), 154.2 (C), 147.6 (CH), 144.6 (CH), 137.5 (CH), 129.9 (CH), 128.4 (CH), 121.4 (CH), 80.9 (C), 79.8 (C), 49.9 (CH), 30.3 (CH3); HRMS (ESI) m/z calcd for C13H11N2O2S [M + H]+: 259.0536, found: 259.0535.
  • 3,5′,5a′-Trimethyl-5a′,7a′-dihydrospiro[cyclohexane-1,7′-oxeto[3′,2′:3,4]benzo[1,2-c][1,2,5]thiadiazole]-2,5-dien-4-one (3e). Light-yellow liquid (13 mg, 15%); 1H NMR (400 MHz, CDCl3) δ 6.93 (d, J = 1.6 Hz, 1H), 6.79 (dd, J = 10.0 Hz, 2.8 Hz, 1H), 6.63 (d, J = 1.2 Hz, 1H), 5.96 (d, J = 10.4 Hz, 1H), 4.42 (s, 1H), 2.05 (d, J = 1.6 Hz, 3H), 1.93 (d, J = 1.6 Hz, 3H), 1.82 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 185.2 (C), 155.9 (C), 154.0 (C), 147.1 (CH), 144.3 (C), 143.4 (CH), 135.9 (C), 129.9 (CH), 118.3 (CH), 82.3 (C), 79.2 (C), 50.9 (CH), 29.0 (CH3), 16.8 (CH3), 15.5 (CH3); HRMS (ESI) m/z calcd for C15H15N2O2S [M + H]+: 287.0849, found: 287.0847.
  • 3,5′,5a′-Trimethyl-5a′,7a′-dihydrospiro[cyclohexane-1,7′-oxeto[3′,2′:3,4]benzo[1,2-c][1,2,5]thiadiazole]-2,5-dien-4-one (3e’). Light-yellow liquid (16 mg, 19%); 1H NMR (400 MHz, CDCl3) δ 7.12 (dd, J = 10.0 Hz, 3.2 Hz, 1H), 6.65 (d, J = 1.6 Hz, 1H), 6.56 (d, J = 1.6 Hz, 1H), 6.20 (d, J = 10.0 Hz, 1H), 4.41 (s, 1H), 2.06 (d, J = 1.2 Hz, 3H), 1.82 (s, 3H), 1.67 (d, J = 1.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 185.1 (C), 155.9 (C), 154.0 (C), 147.6 (CH), 147.0 (C), 139.5 (CH), 137.2 (C), 128.5 (CH), 118.4 (CH), 82.4 (C), 79.4 (C), 50.7 (CH), 29.0 (CH3), 16.8 (CH3), 15.6 (CH3); HRMS (ESI) m/z calcd for C15H15N2O2S [M + H]+: 287.0849, found: 287.0847.
  • 3,5′,5a′-Trimethyl-5a′,7a′-dihydrospiro[cyclohexane-1,7′-oxeto[3′,2′:3,4]benzo[1,2-c][1,2,5]thiadiazole]-2,5-dien-4-one (3f). Light-yellow liquid (17 mg, 17%); 1H NMR (400 MHz, CDCl3) δ 6.94 (dd, J = 3.2 Hz, 1.6 Hz, 1H), 6.82 (dd, J = 10.0 Hz, 3.2 Hz, 1H), 6.66 (d, J = 1.2 Hz, 1H), 5.97 (d, J = 10.0 Hz, 1H), 4.41 (s, 1H), 2.055 (d, J = 1.6 Hz, 3H), 1.935 (d, J = 1.2 Hz, 3H), 1.82 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 185.1 (C), 159.8 (C), 158.7 (C), 147.6 (CH), 144.3 (CH), 143.6 (CH), 135.8 (C), 129.9 (CH), 121.8 (CH), 82.2 (C), 79.0 (C), 53.8 (CH), 28.7 (CH3), 16.7 (CH3), 15.5 (CH3); HRMS (ESI) m/z calcd for C15H15N2O2Se [M + H]+: 335.0293, found: 335.0293.
  • 3,5′,5a′-Trimethyl-5a′,7a′-dihydrospiro[cyclohexane-1,7′-oxeto[3′,2′:3,4]benzo[1,2-c][1,2,5]thiadiazole]-2,5-dien-4-one (3f′). Light-yellow liquid (14 mg, 14%); 1H NMR (400 MHz, CDCl3) 1H NMR (400 MHz, CDCl3) δ 7.13 (dd, J = 10.0 Hz, 2.8 Hz, 1H), 6.68 (d, J = 1.2 Hz, 1H), 6.58 (dd, J = 2.8 Hz, 1.6 Hz, 1H), 6.21 (d, J = 10.0 Hz, 1H), 4.41 (s, 1H), 2.06 (d, J = 0.8 Hz, 3H), 1.82 (d, 3H), 1.67 (d, J = 1.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 185.1 (C), 159.9 (C), 158.9 (C), 147.9 (CH), 147.4 (CH), 139.6 (CH), 137.2 (C), 128.5 (CH), 121.9 (CH), 82.4 (C), 79.2 (C), 53.5 (CH), 28.8 (CH3), 16.7 (CH3), 15.6 (CH3); HRMS (ESI) m/z calcd for C15H15N2O2Se [M + H]+: 335.0293, found: 335.0294.
  • 3,5′,5a′-Trimethyl-5a′,7a′-dihydrospiro[cyclohexane-1,7′-oxeto[3′,2′:3,4]benzo[1,2-c][1,2,5]thiadiazole]-2,5-dien-4-one (3g). Light-yellow liquid (30 mg, 39%); 1H NMR (400 MHz, CDCl3) δ 6.92 (d, J = 1.2 Hz, 1H), δ 6.72 (dd, J = 10.0 Hz, 2.8 Hz, 1H), 6.63 (s, 1H), 6.05 (d, J = 10.4 Hz, 1H), 4.44 (s, 1H), 2.07 (d, J = 1.3 Hz, 3H), 1.93 (s, 3H), 1.81 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 184.8 (C), 15.0 (C), 148.9 (C), 147.2 (CH), 143.2 (C), 142.6 (CH), 136.5 (C), 130.4 (CH), 110.4 (CH), 80.7 (C), 78.1 (C), 44.7 (CH), 28.6 (CH3), 17.2 (CH3), 15.5 (CH3); HRMS (ESI) m/z calcd for C15H14N2NaO3 [M + Na]+: 293.0897, found: 293.0896.
  • 5′,5a′-Dimethyl-5a′,7a′-dihydro-4H-spiro[naphthalene-1,7′-oxeto[3′,2′:3,4]benzo[1,2-c][1,2,5]thiadiazol]-4-one (3h). Light-brown solid (8 mg, 8%); M.p. 119–121 °C; 1H NMR (400 MHz, CDCl3) δ 8.16 (d, J = 8.0 Hz, 1H), 8.08 (d, J = 8.0 Hz 1H), 7.77 (t, J = 7.6 Hz, 1H), 7.54 (t, J = 7.6 Hz, 1H), 7.24 (d, J = 10.4 Hz, 1H), 6.69 (s, 1H), 6.11 (d, J = 10.4 Hz, 1H), 4.57 (s, 1H), 2.16 (s, 3H), 1.97 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 183.3 (C), 155.8 (C), 153.8 (C), 147.4 (C), 146.3 (CH), 143.5 (C), 133.6 (CH), 130.0 (CH), 129.8 (C), 129.1 (CH), 126.7 (CH), 126.4 (CH), 118.4 (CH), 82.2 (C), 81.3 (C), 56.4 (CH), 27.7 (CH3), 16.8 (CH3); HRMS (ESI) m/z calcd for C18H15N2O2S [M + H]+: 323.0849, found: 323.0847.

3.1.2. General Process II: Synthesis of Diaryl Ethers (4a–4n)

To a quartz tube containing a stirring bar, aromatic 1 (0.9 mmol), quinone 2 (0.3 mmol), copper trifluoromethanesulfonate (22 mg, 0.06 mmol), dichloromethane (1.5 mL), and acetonitrile (1.5 mL) were added. The reaction tube was degassed with argon and stirred for 48 h at room temperature under blue LED (λ = 450 nm, 5 W) irradiation. The reaction system was transferred into a single-necked flask. The reaction mixture was concentrated in vacuo and separated by column chromatography (PE/EtOAc = 10:1) to obtain 4.
  • 4-((5,6-Dimethylbenzo[c][1,2,5]thiadiazol-4-yl)oxy)phenol (4a). Light-yellow solid (53 mg, 65%); M.p. 187–188 °C; 1H NMR (400 MHz, CD3COCD3) δ 8.05 (s, 1H), 7.71 (s, 1H), 6.76–6.71 (m, 4H), 2.523 (d, J = 0.8 Hz, 3H), 2.33 (s, 3H); 13C NMR (100 MHz, CD3COCD3) δ 156.1 (C), 153.3 (C), 152.4 (C), 149.7 (C), 143.8 (C), 143.0 (C), 132.0 (C), 117.5 (CH), 117.2 (CH), 116.7 (CH), 21.2 (CH3), 12.9 (CH3); HRMS (ESI) m/z calcd for C14H13N2O2S [M + H]+: 273.0692, found: 273.0692.
  • 4-(Benzo[c][1,2,5]thiadiazol-4-yloxy)phenol (4b). Green solid (49 mg, 67%); M.P. 178–179 °C; 1H NMR (400 MHz, CD3COCD3) δ 8.43 (s, 1H), 7.67 (d, J = 8.8 Hz, 1H), 7.60–7.56 (m, 1H), 7.09–7.07 (m, 2H), 6.95–6.93 (m, 2H), 6.77 (d, J = 7.6 Hz, 1H); 13C NMR (100 MHz, CD3COCD3) δ 157.6 (C), 155.6 (C), 151.9 (C), 149.1 (C), 148.6 (C), 131.2 (CH), 122.4 (CH), 117.3 (CH), 115.5 (CH), 111.6 (CH); HRMS (ESI) m/z calcd for C12H9N2O2S [M + H]+: 245.0379, found: 245.0378.
  • 4-((5,6-Difluorobenzo[c][1,2,5]thiadiazol-4-yl)oxy)phenol (4c). Colorless solid (14 mg, 17%); M.P. 168–169 °C; 1H NMR (400 MHz, CD3COCD3) δ 8.23 (s, 1H), 7.90–7.85 (m, 1H), 6.99 (d, J = 12.8 Hz, 2H), 6.80 (d, J = 10.8 Hz, 2H); 13C NMR (100 MHz, CD3COCD3) δ 155.5 (C, dd, J = 253.0 Hz, 16.0 Hz), 154.6 (C), 151.7 (C), 151.5 (C, d, J = 14.0 Hz), 148.0 (C), 146.5 (C, dd, J = 256.0 Hz, 20.0 Hz), 133.5 (C, d, J = 16.0 Hz), 118.5 (CH), 116.8 (CH), 103.0 (CH, d, J = 21.0 Hz); 19F NMR (100 MHz, CD3COCD3) δ −129.7 (F, dd, J = 4.6 Hz, 2.7 Hz), −149.8 (F, dd, J = 4.5 Hz, 1.8 Hz); HRMS (ESI) m/z calcd for C12H7F2N2O2S [M + H]+: 281.0191, found: 281.0190.
  • 4-((5,6-Dichlorobenzo[c][1,2,5]thiadiazol-4-yl)oxy)phenol (4d). Green solid (57 mg, 61%); M.P. 182–183 °C; 1H NMR (400 MHz, CD3COCD3) δ 8.25 (s, 1H), 8.22 (s, 1H), 6.88 (d, J = 8.8 Hz, 2H), 6.78 (d, J = 9.2 Hz, 2H); 13C NMR (100 MHz, CD3COCD3) δ 154.7 (C), 154.2 (C), 151.4 (C), 149.2 (C), 144.7 (C), 135.8 (C), 127.0 (C), 118.8 (CH), 118.1 (CH), 116.7 (CH); HRMS (ESI) m/z calcd for C12H7Cl2N2O2S [M + H]+: 312.9600, found: 312.9591.
  • 4-((5,6-Dibromobenzo[c][1,2,5]thiadiazol-4-yl)oxy)phenol (4e). Yellow solid (53 mg, 44%); M.P. 183–184 °C; 1H NMR (400 MHz, CD3COCD3) δ 8.41 (s, 1H), 8.21 (s, 1H), 6.85 (d, J = 9.2 Hz, 2H), 6.77 (d, J = 8.8 Hz, 2H); 13C NMR (100 MHz, CD3COCD3) δ 156.0 (C), 154.2 (C), 151.4 (C), 149.4 (C), 146.0 (C), 127.9 (C), 122.3 (CH), 120.5 (C), 118.1 (CH), 116.7 (CH); HRMS (ESI) m/z calcd for C12H7Br2N2O2S [M + H]+: 402.8569, found: 402.8567.
  • 4-((5-Methylbenzo[c][1,2,5]thiadiazol-4-yl)oxy)phenol (4f). Colorless solid (52 mg, 67%); M.P. 133–134 °C; 1H NMR (400 MHz, CDCl3), δ 7.79 (d, J = 8.8 Hz, 1H), 7.53 (d, J = 9.2 Hz, 1H), 6.76–6.71 (m, 4H), 5.05 (s, 1H) 2.41 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 155.5 (C), 152.0 (C), 150.7 (C), 149.9 (C), 143.1 (C), 133.8 (CH), 130.4 (C), 117.6 (CH), 116.5 (CH), 116.2 (CH), 15.8 (CH3); HRMS (ESI) m/z calcd for C13H11N2O2S [M + H]+: 259.0536, found: 259.0534.
  • 4-((5-Methoxybenzo[c][1,2,5]thiadiazol-4-yl)oxy)phenol (4g). Green solid (45 mg, 55%); M.P. 149–150 °C; 1H NMR (400 MHz, CDCl3), δ 7.85 (d, J = 9.2 Hz, 1H), 7.56 (d, J = 9.6 Hz, 1H), 6.86–6.82 (m, 2H), 6.75–6.71 (m, 2H), 4.01 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 152.2 (C), 152.1 (C), 151.5 (C), 150.7 (C), 132.8 (C), 121.9 (CH), 118.0 (CH), 116.7 (CH), 116.1 (CH), 58.3 (CH3); HRMS (ESI) m/z calcd for C13H11N2O3S [M + H]+: 275.0485, found: 275.0483.
  • 4-((5-Fluorobenzo[c][1,2,5]thiadiazol-4-yl)oxy)phenol (4h). Yellow solid (27 mg, 34%); M.P. 159–160 °C; 1H NMR (400 MHz, CD3COCD3), δ 8.20 (s, 1H), 7.96 (dd, J = 9.2 Hz, 4.4 Hz, 1H), 7.78 (dd, J = 10.8 Hz, 10.0 Hz, 1H), 6.94–6.90 (m, 2H), 6.81–6.77 (m, 2H); 13C NMR (100 MHz, CD3COCD3) δ 155.4 (C, d, J = 249.0 Hz), 154.2 (C), 154.1 (C), 152.1 (C), 151.3 (C, d, J = 7.0 Hz), 133.5 (C, d, J = 14.0 Hz), 122.9 (CH, d, J = 26.0 Hz), 119.0 (CH, d, J = 10.0 Hz), 118.0 (CH), 116.7 (CH); 19F NMR (100 MHz, CD3COCD3) δ −130.8 (F, d, J = 2.0 Hz); HRMS (ESI) m/z calcd for C12H8FN2O2S [M + H]+: 263.0285, found: 263.0284.
  • 4-((6-Fluorobenzo[c][1,2,5]thiadiazol-4-yl)oxy)phenol (4h′). Colorless solid (12 mg, 15%); M.P. 200–202 °C; 1H NMR (400 MHz, CD3COCD3), δ 8.59 (s, 1H), 7.38 (dd, J = 9.2 Hz, 2.4 Hz, 1H), 7.17–7.15 (m, 2H), 7.00–6.98 (m, 2H), 6.57 (dd, J = 11.2 Hz, 2.4 Hz, 1H); 13C NMR (100 MHz, CD3COCD3) δ 165.4 (C, d, J = 248.0 Hz), 156.7 (C, d, J = 14.0 Hz), 156.3 (C), 152.8 (C, d, J = 15.0 Hz), 147.7 (C), 146.7 (C), 122.8 (CH), 117.6 (CH), 102.9 (d, J = 34.0 Hz, CH), 98.7 (d, J = 25.0 Hz, CH); 19F NMR (100 MHz, CD3COCD3) δ −108.4 (F); HRMS (ESI) m/z calcd for C12H8FN2O2S [M + H]+: 263.0285, found: 263.0284.
  • 4-((5-Chlorobenzo[c][1,2,5]thiadiazol-4-yl)oxy)phenol (4i). Green solid (47 mg, 56%); M.P. 154–156 °C; 1H NMR (400 MHz, CD3COCD3), δ 8.13 (s, 1H), 7.94 (d, J = 9.2 Hz, 1H), 7.82 (d, J = 9.2 Hz, 1H), 6.86–6.82 (m, 2H), 6.79–6.75 (m, 2H); 13C NMR (100 MHz, CD3COCD3) δ 156.4 (C), 154.7 (C), 151.8 (C), 150.9 (C), 143.8 (C), 132.5 (CH), 127.6 (C), 119.3 (CH), 118.1 (CH), 116.8 (CH); HRMS (ESI) m/z calcd for C12H8ClN2O2S [M + H]+: 278.9990, found: 278.9987.
  • 4-((6-Chlorobenzo[c][1,2,5]thiadiazol-4-yl)oxy)phenol (4i′). Green solid (16 mg, 19%); M.P. 160–162 °C; 1H NMR (400 MHz, CD3COCD3), δ 8.59 (s, 1H), 7.73 (d, J = 2 Hz, 1H), 7.18–7.13 (m, 2H), 7.00–6.97 (m, 2H), 6.64 (d, J = 2 Hz, 1H); 13C NMR (100 MHz, CD3COCD3) δ 156.9 (C), 156.2 (C), 152.2 (C), 147.8 (C), 147.7 (C), 137.3 (C), 122.7 (CH), 117.6 (CH), 114.3 (CH), 112.3 (CH); HRMS (ESI) m/z calcd for C12H8ClN2O2S [M + H]+: 278.9990, found: 278.9987.
  • 4-((5-Bromobenzo[c][1,2,5]thiadiazol-4-yl)oxy)phenol (4j). Brown solid (53 mg, 55%); M.P. 174–175 °C; 1H NMR (400 MHz, CD3COCD3), δ 8.17 (s, 1H), 7.95 (d, J = 9.2 Hz, 1H), 7.88 (d, J = 9.2 Hz, 1H), 6.85–6.81 (m, 2H), 6.79–6.75 (m, 2H); 13C NMR (100 MHz, CD3COCD3) δ 156.8 (C), 154.0 (C), 151.7 (C), 150.8 (C), 145.2 (C), 134.9 (CH), 119.5 (CH), 118.0 (CH), 117.1 (C), 116.7 (CH); HRMS (ESI) m/z calcd for C12H8BrN2O2S [M + H]+: 322.9484, found: 322.9483.
  • 4-((6-Bromobenzo[c][1,2,5]thiadiazol-4-yl)oxy)phenol (4j′). Light-yellow solid (10 mg, 10%); M.P. 173–174 °C; 1H NMR (400 MHz, CD3COCD3), δ 8.61 (s, 1H), 7.926 (d, J = 1.6 Hz, 1H), 7.18–7.14 (m, 2H), 7.01–6.97 (m, 2H), 6.748 (d, J = 1.6 Hz, 1H); 13C NMR (100 MHz, CD3COCD3) δ 157.5 (C), 156.2 (C), 152.2 (C), 148.0 (C), 147.7 (C), 125.2 (C), 122.8 (CH), 117.7 (CH), 117.6 (CH), 114.6 (CH); HRMS (ESI) m/z calcd for C12H8BrN2O2S [M + H]+: 322.9484, found: 322.9483.
  • 7-(4-Hydroxyphenoxy)benzo[c][1,2,5]thiadiazole-5-carbaldehyde (4k). Brown solid (40 mg, 49%); M.P. 199–201 °C; 1H NMR (400 MHz, CD3COCD3); δ 10.16 (s, 1H), 8.54 (s, 1H), 8.364 (d, J = 1.2 Hz, 1H), 7.17–7.13 (m, 2H), 7.105 (d, J = 1.2 Hz, 1H), 7.01–6.97 (m, 2H); 13C NMR (100 MHz, CD3COCD3) δ 192.3 (CH) 157.2 (C), 156.1 (C), 153.0 (C), 151.4 (C), 147.8 (C), 139.4 (C), 122.8 (CH), 122.3 (CH), 117.5 (CH), 105.8 (CH); HRMS (ESI) m/z calcd for C13H9N2O3S [M + H]+: 273.0328, found: 273.0327.
  • 4-((7-Methylbenzo[c][1,2,5]thiadiazol-4-yl)oxy)phenol (4l). Yellow solid (45 mg, 58%); M.p. 204–206 °C; 1H NMR (400 MHz, CD3COCD3); δ 8.37 (s, 1H), 7.34 (d, J = 6.4 Hz, 1H), 7.04 (dd, J = 6.4 Hz, 2 Hz, 1H), 6.91 (d, J = 4.4 Hz, 1H), 6.74 (d, J = 7.6 Hz, 1H), 2.63 (s, 3H); 13C NMR (100 MHz, CD3COCD3) δ 156.7 (C), 154.3 (C), 148.7 (C), 148.3 (C), 148.2 (C), 128.3 (CH), 124.6 (C), 121.0 (CH), 116.3 (CH), 111.9 (CH), 16.4 (CH3); HRMS (ESI) m/z calcd for C13H10N2O2S [M]+: 258.0457, found: 258.0461.
  • 4-(4-Hydroxyphenoxy)-6-methylbenzo[c][1,2,5]thiadiazole-5-carbaldehyde (4m). Yellow solid (19 mg, 22%); M.p. 175–177 °C; 1H NMR (400 MHz, CD3COCD3); δ 10.46 (s, 1H), 8.51 (s, 1H), 8.07 (s, 1H), 6.79–6.74 (m, 4H), 2.68 (s, 3H); 13C NMR (100 MHz, CD3COCD3) δ 193.5 (CH), 155.4 (C), 153.7 (C), 152.4 (C), 152.3 (C), 145.5 (C), 138.7 (C), 130.6 (C), 126.0 (CH), 117.6 (CH), 116.9 (CH), 12.5 (CH3); HRMS (ESI) m/z calcd for C14H11N2O3S [M + H]+: 287.0485, found: 287.0486.
  • 4-((6-Bromo-5-methylbenzo[c][1,2,5]thiadiazol-4-yl)oxy)phenol (4n). Yellow solid (41 mg, 41%); M.P. 180–181 °C; 1H NMR (400 MHz, CD3COCD3); δ 8.22 (s, 1H), 6.75 (s, 4H), 4.62(s, 1H), 2.50 (s, 3H); 13C NMR (100 MHz, CD3COCD3) δ 156.7 (C), 153.7 (C), 152.2 (C), 149.9 (C), 144.6 (C), 131.2 (C), 129.8 (C), 121.7 (CH), 117.6 (CH), 116.8 (CH), 16.9 (CH3); HRMS (ESI) m/z calcd for C13H10BrN2O2S [M + H]+: 336.9641, found: 336.9639.
  • 4-((5-Bromo-6-methylbenzo[c][1,2,5]thiadiazol-4-yl)oxy)phenol (4n′). Colorless solid (34 mg, 34%); M.P. 173–174 °C; 1H NMR (400 MHz, CD3COCD3); δ 7.77 (s, 1H), 6.83 (d, J = 8.8 Hz, 2H), 6.75 (d, J = 8.8 Hz, 2H), 4.63 (s, 1H), 2.67 (d, J = 0.8 Hz, 3H); 13C NMR (100 MHz, CD3COCD3) δ 156.2 (C), 153.9 (C), 151.6 (C), 149.2 (C), 144.9 (C), 141.5 (C), 121.8 (C), 118.0 (CH), 117.9 (CH), 116.7 (CH), 24.3 (CH3);HRMS (ESI) m/z calcd for C13H10BrN2O2S [M + H]+: 336.9641, found: 336.9639.

3.1.3. General Process III: Synthesis of Diaryl Ethers (4o–4u)

To a quartz tube containing a stirring bar, aromatic 1 (0.9 mmol), quinone 2 (0.3 mmol), copper trifluoromethanesulfonate (22 mg, 0.06 mmol), dichloromethane (1.5 mL), and acetonitrile (1.5 mL) were added. The reaction tube was degassed with argon and stirred for 48 h at −40 °C under blue LED (λ = 450 nm, 5 W) irradiation. The reaction system was raised to room temperature and transferred into a single-necked flask. The reaction mixture was concentrated in vacuo and separated by column chromatography (PE/EtOAc = 10:1) to obtain 4.
  • 4-Phenoxyphenol (4o) [50]. Colorless solid (54 mg, 95%); M.P. 83–84 °C; 1H NMR (400 MHz, CDCl3) δ 7.33–7.29 (m, 2H), 7.05 (t, J = 7.4 Hz, 1H), 6.96–6.93 (m, 4H), 6.84–6.80 (m, 2H), 4.85 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 158.4 (C), 151.6 (C), 150.2 (C), 129.6 (CH), 122.5 (CH), 121.0 (CH), 117.6 (CH), 116.3 (CH); HRMS (ESI) m/z calcd for C12H11O2 [M + H]+: 187.0754, found: 187.0751.
  • 3-(4-Hydroxyphenoxy)-2,4,6-trimethylbenzoate (4p). Colorless solid (55 mg, 64%); M.P. 153–154 °C; 1H NMR (400 MHz, CDCl3) δ 6.93 (s, 1H), 6.69 (d, J = 8.8 Hz, 2H), 6.59 (d, J = 8.8 Hz, 2H), 5,09 (s, 1H), 3.91 (s, 3H), 2.28 (s, 3H), 2.075 (s, 3H), 2.071 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 170.4 (C), 151.6 (C), 150.0 (C), 149.3 (C), 133.1 (C), 131.4 (C), 130.6 (CH), 128.8 (C), 116.1 (CH), 115.3 (CH), 52.1 (CH3), 19.3(CH3), 16.4 (CH3), 13.5 (CH3); HRMS (ESI) m/z calcd for C17H19O4 [M + H]+: 287.1278, found: 287.1277.
  • 4-(Naphthalen-1-yloxy)phenol (4q). Colorless liquid (61 mg, 87%); 1H NMR (400 MHz, CDCl3) δ 8.31 (d, J = 8.8 Hz, 1H), 7.88 (d, J = 8.8 Hz, 1H), 7.58–7.52 (m, 3H), 7.35 (t, J = 8.0 Hz, 1H), 7.00 (d, J = 8.8 Hz, 2H), 6.85–6.81 (m, 3H), 4.32 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 154.3 (C), 151.6 (C), 150.7 (C), 134.8 (C), 127.6 (CH), 126.6 (CH), 126.3 (C), 125.8 (CH), 125.7 (CH), 122.4 (CH), 122.0 (CH), 120.7 (CH), 116.4 (CH), 111.3 (CH); HRMS (ESI) m/z calcd for C16H13O2 [M + H]+: 237.0910, found: 237.0908.
  • 4-(Benzo[c][1,2,5]thiadiazol-4-yloxy)-2-methylphenol (4r). Light-yellow solid (28 mg, 34%); M.P. 142–143 °C; 1H NMR (400 MHz, CDCl3), δ 7.62 (dd, J = 8.8 Hz, 0.8 Hz, 1H), 7.41–7.37 (m, 1H), 6.87 (d, J = 8.4 Hz 1H), 6.72 (d, J = 8.8 Hz, 1H), 6.43 (dd, J = 7.6 Hz, 0.8 Hz, 1H), 5.25 (s, 1H), 2.23 (s, 3H), 2.12 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 156.5 (C), 151.1 (C), 150.9 (C), 147.9 (C), 146.0 (C), 130.7 (C), 130.1 (CH), 124.6 (C), 119.2 (CH), 114.2 (CH), 113.3 (CH), 109.0 (CH), 12.8 (CH3), 12.2 (CH3). HRMS (ESI) m/z calcd for C14H12N2O2S [M + H]+: 273.0692, found: 273.0692.
  • 2,3-Dimethyl-4-phenoxyphenol (4s). Colorless solid (28 mg, 44%); M.P. 79–80 °C; 1H NMR (400 MHz, CDCl3) δ 7.28–7.24 (m, 1H), 6.98 (t, J = 7.6 Hz, 1H), 6.82 (d, J = 8.0 Hz, 2H), 6.74 (d, J = 8.4 Hz, 1H), 6.63 (d, J = 8.4 Hz, 1H), 4.63 (s, 1H), 2.21 (s, 3H), 2.12 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 159.0 (C), 150.2 (C), 147.2 (C), 130.8 (C), 129.5 (CH), 124.2 (C), 121.5 (CH), 119.0 (CH), 116.0 (CH), 113.0 (CH), 12.8 (CH3), 12.1 (CH3); HRMS (ESI) m/z calcd for C14H15O2 [M + H]+: 215.1067, found: 215.1064.
  • 4-(Benzo[c][1,2,5]thiadiazol-4-yloxy)-2-chlorophenol (4t). Light-yellow solid (20 mg, 24%); M.P. 140–142 °C; 1H NMR (400 MHz, CDCl3), δ 7.71 (d, J = 8.8 Hz, 1H), 7.49–7.45 (m, 1H), 7.20 (d, J = 2.4 Hz, 1H), 7.09–7.03 (m, 2H), 6.78 (d, J = 7.2 Hz, 1H), 5.51 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 150.0 (C) δ 148.7 (C), δ 148.5 (C), δ 129.8 (CH), δ 121.0 (CH), δ 120.7 (CH), δ 120.2 (C), δ 117.0 (CH), δ 115.8 (CH), δ 111.5 (CH); HRMS (ESI) m/z calcd for C12H8ClN2O2S [M + H]+: 278.9990, found: 278.9986.
  • 2-Chloro-4-phenoxyphenol (4u) [51]. Red liquid (59 mg, 89%); 1H NMR (400 MHz, CDCl3) δ 7.36–7.32 (m, 2H), 7.11 (t, J = 7.2 Hz, 1H), 7.055 (d, J = 2.4 Hz, 1H), 7.03–6.97 (m, 3H), 6.915 (dd, J = 8.8 Hz, 2.8 Hz, 1H), 5.48 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 157.6 (C), 150.2 (C), 147.6 (C), 129.7 (CH), 123.1 (CH), 120.0 (CH), 119.97 (CH), 119.7 (C), 117.9 (CH), 116.7 (CH); HRMS (ESI) m/z calcd for C12H10ClO2 [M + H]+: 221.0364, found: 221.0360.

3.1.4. Synthesis of 5

  • 4-((4,6-Dimethylbenzo[c][1,2,5]thiadiazol-5-yl)oxy)phenol (5). Compound 3a (82 mg, 0.30 mmol) was dissolved in a mixed solvent of acetonitrile and dichloromethane and then copper triflate (22 mg, 0.06 mmol) was added in an argon atmosphere. After TLC monitoring, the raw material disappeared. Then, the solvent was directly removed for column chromatography (PE/EtOAc = 10:1). Green solid (8 mg, 10%); M.P. 142–144 °C; 1H NMR (400 MHz, CDCl3) δ 7.71 (s, 1H), 6.75 (d, J = 8.8 Hz, 2H),6.69 (d, J = 8.8 Hz, 2H), 4.71 (s, 1H), 2.53 (s, 3H), 2.30 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 155.4, 152.7, 152.4, 151.7, 150.4, 137.2, 122.4, 118.6, 116.4, 115.6, 18.2, 11.9; HRMS (ESI) m/z calcd for C14H13N2O2S [M + H]+: 273.0692, found: 273.0692.

3.2. X-ray Crystallographic Analysis

The structure of 3a, 4b, 4k, 4n, 4t, and 5 was confirmed based on single-crystal X-ray analysis.
CCDC No. 2121130 (3a), 2091206 (4b), 2121129 (4k), 2121131 (4n), 2091197 (4t), and 2091205 (5) contain the supplementary crystallographic data for this paper. The crystal data can be obtained free of charge from the Cambridge Crystallographic Data Centre at www.ccdc.cam.ac.uk/datarequest/cif (accessed on 9 September 2022).

4. Conclusions

In summary, a PB reaction between aromatics and quinones under visible light irradiation was developed. The PB reactions between aromatics and quinones were accomplished via activation of the benzene ring double bond using the combination of thiadiazole, oxadiazole, or selenadiazole under blue LED irradiation, resulting in the synthesis of oxetanes with an obvious substituent effect. The addition of Cu(OTf)2 opened the generated oxetane rings in situ to transform into diaryl ethers, which expanded the range of substrate adaptation.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules29071513/s1, Figure S1: UV-vis absorption spectra of 2a; Figure S2: The fluorescence spectra of 2a; Figure S3: Cyclic voltammetry (CV) curve of 1a; Table S1: Optimization of the reaction conditions for the synthesis of diaryl ethers; Crytallographic data; Copies of NMR spectra; DFT calculations data. References [13,47,52,53,54] are cited in the Supplementary Materials.

Author Contributions

Investigation, W.-W.L., J.-L.Z., Z.-Y.W., P.-T.L. and Z.-F.S.; Writing—original draft, W.-W.L.; Writing—review & editing, Z.-F.S., X.-P.C. and Q.L.; Supervision, Z.-F.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Science and Technology Major Program of Gansu Province of China (22ZD6FA006) and the National Natural Science Foundation of China (Grant Nos. 21572086, 21572085).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are contained within the article and Supplementary Materials.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Shimada, N.; Hasegawa, S.; Harada, T.; Tomisawa, T.; Fujii, A.; Takita, T. Oxetanocin, a novel nucleoside from bacteria. J. Antibiot. 1986, 39, 1623–1625. [Google Scholar] [CrossRef] [PubMed]
  2. Bhagwat, S.S.; Hamann, P.R.; Still, W.C. Synthesis of thromboxane A2. J. Am. Chem. Soc. 1985, 107, 6372–6376. [Google Scholar] [CrossRef]
  3. Omura, S.; Murata, M.; Imamura, N.; Iwai, Y.; Tanaka, H.; Furusaki, A.; Matsumoto, H. Oxetin, a new antimetabolite from an actinomycete fermentation, isolation, structure and biological activity. J. Antibiot. 1984, 37, 1324–1332. [Google Scholar] [CrossRef]
  4. Loh, J.; Carlson, R.W.; York, W.S.; Stacey, G. Bradyoxetin, a unique chemical signal involved in symbiotic gene regulation. Proc. Natl. Acad. Sci. USA 2002, 99, 14446–14451. [Google Scholar] [CrossRef] [PubMed]
  5. Wang, J.-P.; Shu, Y.; Liu, S.-X.; Hu, J.-T.; Sun, C.-T.; Zhou, H.; Gan, D.; Cai, X.-Y.; Pu, W.; Cai, L.; et al. Expanstines A–D: Four unusual isoprenoid epoxycyclohexenones generated by Penicillium expansum YJ-15 fermentation and photopromotion. Org. Chem. Front. 2019, 6, 3839–3846. [Google Scholar] [CrossRef]
  6. Becker, M.R.; Wearing, E.R.; Schindler, C.S. Synthesis of azetidines via visible-light-mediated intermolecular [2+2] photocycloadditions. Nat. Chem. 2020, 12, 898–905. [Google Scholar] [CrossRef] [PubMed]
  7. Richardson, A.D.; Becker, M.R.; Schindler, C.S. Synthesis of azetidines by aza Paternò-Büchi reactions. Chem. Sci. 2020, 11, 7553–7561. [Google Scholar] [CrossRef]
  8. Kandappa, S.K.; Valloli, L.K.; Ahuja, S.; Parthiban, J.; Sivaguru, J. Taming the excited state reactivity of imines—From non-radiative decay to aza Paternò-Büchi reaction. Chem. Soc. Rev. 2021, 50, 1617–1641. [Google Scholar] [CrossRef] [PubMed]
  9. Li, X.; Grosskopf, J.; Jandl, C.; Bach, T. Enantioselective, visible light mediated aza Paternò-Büchi reactions of quinoxalinones. Angew. Chem. Int. Ed. 2021, 60, 2684–2688. [Google Scholar] [CrossRef] [PubMed]
  10. D’Auria, M. The Paternò-Büchi reaction–a comprehensive review. Photochem. Photobiol. Sci. 2019, 18, 2297–2362. [Google Scholar] [CrossRef]
  11. Flores, D.M.; Schmidt, V.A. Intermolecular 2 + 2 Carbonyl-Olefin Photocycloadditions Enabled by Cu(I)-Norbornene MLCT. J. Am. Chem. Soc. 2019, 141, 8741–8745. [Google Scholar] [CrossRef] [PubMed]
  12. Franceschi, P.; Mateos, J.; Vega-Penaloza, A.; Dell’Amico, L. Microfluidic visible-light Paternò-Büchi reaction of oxindole enol ethers. Eur. J. Org. Chem. 2020, 2020, 6718–6722. [Google Scholar] [CrossRef]
  13. Fréneau, M.; Hoffmann, N. The Paternò-Büchi reaction–Mechanisms and application to organic synthesis. J. Photochem. Photobiol. C Photochem. Rev. 2017, 33, 83–108. [Google Scholar] [CrossRef]
  14. Buchi, G.; Ihman, C.G.; Lipinsky, E.S. Light-catalyzed organic reactions. I. The reaction of carbonyl compounds with 2-methyl-2-butene in the presence of ultraviolet light. J. Am. Chem. Soc. 1954, 76, 4327–4331. [Google Scholar] [CrossRef]
  15. Paterno, E.; Chieffi, G. Sintesi in chimica organica per mezzo della luce. Composti degli idrocarbun non saturi con aldeidi e chetoni. Gazz. Chim. Ital. 1909, 39, 341–361. [Google Scholar]
  16. Friedrich, L.E.; Bower, J.D. Detection of an oxetene intermediate in the photoreaction of benzaldehyde with 2-butyne. J. Am. Chem. Soc. 1973, 95, 6869–6870. [Google Scholar] [CrossRef]
  17. D’Auria, M.; Racioppi, R.; Romaniello, G. The Paternò-Büchi reaction of 2-furylmethanols. Eur. J. Org. Chem. 2000, 2000, 3265–3272. [Google Scholar] [CrossRef]
  18. D’Auria, M.; Racioppi, R. Paterno-Büchi reaction on 5-methyl-2-furylmethanol derivatives. Arkivoc 2000, 2000, 133–140. [Google Scholar] [CrossRef]
  19. Vargas, F.; Rivas, C.; Navarro, M.; Alvarado, Y. Synthesis of an elusive oxetane by photoaddition of benzophenone to thiophene in the presence of a Lewis acid. J. Photochem. Photobiol. A Chem. 1996, 93, 169–171. [Google Scholar] [CrossRef]
  20. Capozzo, M.; D’Auria, M.; Emanuele, L.; Racioppi, R. Synthesis and photochemical reactivity towards the Paternò-Büchi reaction of benzo[b]furan derivatives: Their use in the preparation of 3-benzofurylmethanol derivatives. J. Photochem. Photobiol. A Chem. 2007, 185, 38–43. [Google Scholar] [CrossRef]
  21. Rivas, C.; Velez, M.; Crescente, O. Synthesis of an oxetan by photoaddition of benzophenone to a thiophen derivative. Chem. Commun. 1970, 1474. [Google Scholar] [CrossRef]
  22. Jones, G.; Gilow, H.M.; Low, J. Regioselective photoaddition of pyrroles and aliphatic carbonyl compounds. A new synthesis of 3(4)-substituted pyrroles. J. Org. Chem. 1979, 44, 2949–2951. [Google Scholar] [CrossRef]
  23. Rivas, C.; Bolivar, R.A. Synthesis of oxetanes by photoaddition of carbonyl compounds to pyrrole derivatives. J. Heterocycl. Chem. 1976, 13, 1037–1040. [Google Scholar] [CrossRef]
  24. Matsuura, T.; Banba, A.; Ogura, K. Photoinduced reactions–XLV: Photoaddition of ketones to methylimidazoles. Tetrahedron 1971, 27, 1211–1219. [Google Scholar] [CrossRef]
  25. Nakano, T.; Rodriguez, W.; De Roche, S.Z.; Larrauri, J.M.; Rivas, C.; Perez, C. Photoaddition of ketones to imidazoles, thiazoles, isothiazoles and isoxazoles. Synthesis of their oxetanes. J. Heterocycl. Chem. 1980, 17, 1777–1780. [Google Scholar] [CrossRef]
  26. Griesbeck, A.G.; Fiege, M.; Lex, J. Oxazole–Carbonyl photocycloadditions: Selectivity pattern and synthetic route to erythro α-amino, β-hydroxy ketones. Chem. Commun. 2000, 7, 589–590. [Google Scholar] [CrossRef]
  27. Mateos, J.; Vega-Penaloza, A.; Franceschi, P.; Rigodanza, F.; Andreetta, P.; Companyo, X.; Pelosi, G.; Bonchio, M.; Dell’Amico, L. A visible-light Paternò-Büchi dearomatisation process towards the construction of oxeto-indolinic polycycles. Chem. Sci. 2020, 11, 6532–6538. [Google Scholar] [CrossRef] [PubMed]
  28. Wang, T.; Stein, P.M.; Shi, H.; Hu, C.; Rudolph, M.; Hashmi, A.S.K. Hydroxylamine-mediated C–C amination via an aza-hock rearrangement. Nat. Commun. 2021, 12, 7029. [Google Scholar] [CrossRef] [PubMed]
  29. Wang, T.; Hoffmann, M.; Dreuw, A.; Hasagić, E.; Hu, C.; Stein, P.M.; Witzel, S.; Shi, H.; Yang, Y.; Rudolph, M.; et al. A Metal-Free Direct Arene C−H Amination. Adv. Synth. Catal. 2021, 363, 2783–2795. [Google Scholar] [CrossRef]
  30. Becker, M.R.; Richardson, A.D.; Schindler, C.S. Functionalized azetidines via visible light-enabled aza Paternò-Büchi reactions. Nat. Commun. 2019, 10, 5095. [Google Scholar] [CrossRef] [PubMed]
  31. Blum, T.R.; Miller, Z.D.; Bates, D.M.; Guzei, I.A.; Yoon, T.P. Enantioselective photochemistry through Lewis acid-catalyzed triplet energy transfer. Science 2016, 354, 1391–1395. [Google Scholar] [CrossRef] [PubMed]
  32. Strieth-Kalthoff, F.; James, M.J.; Teders, M.; Pitzer, L.; Glorius, F. Energy transfer catalysis mediated by visible light: Principles, applications, directions. Chem. Soc. Rev. 2018, 47, 7190–7202. [Google Scholar] [CrossRef] [PubMed]
  33. Zhou, Z.; LaPointe, A.M.; Shaffer, T.D.; Coates, G.W. Nature-inspired methylated polyhydroxybutyrates from C1 and C4 feedstocks. Nat. Chem. 2023, 15, 856–861. [Google Scholar] [CrossRef] [PubMed]
  34. Getzler, Y.D.Y.L.; Kundnani, V.; Lobkovsky, E.B.; Coates, G.W. Catalytic Carbonylation of β-Lactones to Succinic Anhydrides. J. Am. Chem. Soc. 2004, 126, 6842–6843. [Google Scholar] [CrossRef]
  35. Theil, F. Synthesis of diaryl ethers: A long-standing problem has been solved. Angew. Chem. Int. Ed. 1999, 38, 2345–2347. [Google Scholar] [CrossRef]
  36. Rao, A.V.R.; Gurjar, M.K.; Reddy, K.L.; Rao, A.S. Studies directed toward the synthesis of vancomycin and related cyclic peptides. Chem. Rev. 1995, 95, 2135–2167. [Google Scholar] [CrossRef]
  37. Zhu, J. SNAr bases macrocyclization via biaryl ether formation: Application in natural product synthesis. Synlett 1997, 1997, 133–144. [Google Scholar] [CrossRef]
  38. Boger, D.L.; Borzilleri, R.M.; Nukui, S.; Beresis, R.T. Synthesis of the vancomycin CD and DE ring systems. J. Org. Chem. 1997, 62, 4721–4736. [Google Scholar] [CrossRef]
  39. Mulla, S.A.R.; Inamdar, S.M.; Pathan, M.Y.; Chavan, S.S. Ligand free, highly efficient synthesis of diaryl ether over copper fluorapatite as heterogeneous reusable catalyst. Tetrahedron Lett. 2012, 53, 1826–1829. [Google Scholar] [CrossRef]
  40. Zhang, Y.; Ni, G.; Li, C.; Xu, S.; Zhang, Z.; Xie, X. The coupling reactions of aryl halides and phenols catalyzed by palladium and MOP-type ligands. Tetrahedron 2015, 71, 4927–4932. [Google Scholar] [CrossRef]
  41. Cristau, H.-J.; Cellier, P.P.; Hamada, S.; Spindler, J.-F.; Taillefer, M. A general and mild ullmann-type synthesis of fiaryl ethers. Org. Lett. 2004, 6, 913–916. [Google Scholar] [CrossRef]
  42. Munoz, A.; Leo, P.; Orcajo, G.; Martínez, F.; Calleja, G. URJC-1-MOF as new heterogeneous recyclable catalyst for C-Heteroatom coupling reactions. ChemCatChem 2019, 11, 3376–3380. [Google Scholar] [CrossRef]
  43. Cermak, J.K.; Cirkva, V. Copper-mediated synthesis of mono- and dichlorinated diaryl ethers. Tetrahedron Lett. 2014, 55, 4185–4188. [Google Scholar] [CrossRef]
  44. Chan, D.M.T.; Monaco, K.L.; Wang, R.-P.; Winters, M.P. New N- and O-arylations with phenylboronic acids and cupric acetate. Tetrahedron Lett. 1998, 39, 2933–2936. [Google Scholar] [CrossRef]
  45. Evans, D.A.; Katz, J.L.; West, T.R. Synthesis of diaryl ethers through the copper-promoted arylation of phenols with arylboronic acids. An expedient synthesis of thyroxine. Tetrahedron Lett. 1998, 39, 2937–2940. [Google Scholar] [CrossRef]
  46. Sang, R.; Korkis, S.E.; Su, W.; Ye, F.; Engl, P.S.; Berger, F.; Ritter, T. Site-selective C−H oxygenation via aryl sulfonium salts. Angew. Chem. Int. Ed. 2019, 58, 16161–16166. [Google Scholar] [CrossRef]
  47. Sharma, A.; Dixit, V.; Kumar, S.; Jain, N. Visible Light-Mediated In Situ Generation of δ,δ-Disubstituted p-Quinone Methides: Construction of a Sterically Congested Quaternary Stereocenter. Org. Lett. 2021, 23, 3409–3414. [Google Scholar] [CrossRef]
  48. Franceschi, P.; Cuadros, S.; Goti, G.; Dell’Amico, L. Mechanisms and Synthetic Strategies in Visible Light-Driven [2+2]-Heterocycloadditions. Angew. Chem. Int. Ed. 2023, 62, e202217210. [Google Scholar] [CrossRef]
  49. Ciufolini, M.A.; Rivera-Fortin, M.A.; Zuzukin, V.; Whitmire, K.H. Origin of Regioselectivity in Paterno-Buechi Reactions of Benzoquinones with Alkylidenecycloalkanes. J. Am. Chem. Soc. 1994, 116, 1272–1277. [Google Scholar] [CrossRef]
  50. Janssen, D.E.; VanAllan, J.; Wilson, C.V. The synthesis of 4-phenoxycatechol and 2-phenoxyhydroquinone. J. Org. Chem. 1955, 20, 1326–1329. [Google Scholar] [CrossRef]
  51. Koyama, H.; Miller, D.J.; Boueres, J.K.; Desai, R.C.; Jones, A.B.; Berger, J.P.; MacNaul, K.L.; Kelly, L.J.; Doebber, T.W.; Wu, M.S.; et al. (2R)-2-Ethylchromane-2-carboxylic Acids: Discovery of Novel PPARα/γ Dual Agonists as Antihyperglycemic and Hypolipidemic Agents. J. Med. Chem. 2004, 47, 3255–3263. [Google Scholar] [CrossRef]
  52. Sagadevan, A.; Ragupathi, A.; Hwang, K.C. Photoinduced Copper-Catalyzed Regioselective Synthesis of Indoles: Three-Component Coupling of Arylamines, Terminal Alkynes, and Quinones. Angew. Chem. Int. Ed. 2015, 54, 13896–13901. [Google Scholar] [CrossRef] [PubMed]
  53. Schnapp, K.A.; Wilson, R.M.; Ho, D.M.; Caldwell, R.A.; Creed, D. Benzoquinone-olefin exciplexes: The observation and chemistry of the p-benzoquinone-tetraphenylallene exciplex. J. Am. Chem. Soc. 1990, 112, 3700–3702. [Google Scholar] [CrossRef]
  54. Yang, J.; Duan, J.; Wang, G.; Zhou, H.; Ma, B.; Wu, C.; Xiao, J. Visible-Light-Promoted Site-Selective N(1)-Alkylation of Benzotriazoles with alpha-Diazoacetates. Org. Lett. 2020, 22, 7284–7289. [Google Scholar] [CrossRef] [PubMed]
Molecules 29 01513 sch001
Scheme 1. Selected examples of the Paternò–Büchi reaction.
Scheme 1. Selected examples of the Paternò–Büchi reaction.
Molecules 29 01513 sch001
Molecules 29 01513 sch002
Scheme 2. Substrate scope of the Paternò–Büchi reaction of aromatic with quinones.
Scheme 2. Substrate scope of the Paternò–Büchi reaction of aromatic with quinones.
Molecules 29 01513 sch002
Molecules 29 01513 sch003
Scheme 3. The reaction of 1a and 2a catalyzed by Cu(OTf)2.
Scheme 3. The reaction of 1a and 2a catalyzed by Cu(OTf)2.
Molecules 29 01513 sch003
Molecules 29 01513 sch004
Scheme 4. Substrate scope for the synthesis of diaryl ethers.
Scheme 4. Substrate scope for the synthesis of diaryl ethers.
Molecules 29 01513 sch004
Molecules 29 01513 sch005
Scheme 5. Control experiments.
Scheme 5. Control experiments.
Molecules 29 01513 sch005
Molecules 29 01513 sch006
Scheme 6. Speculated mechanism.
Scheme 6. Speculated mechanism.
Molecules 29 01513 sch006
Table 1. The Paternò–Büchi reaction of aromatic with quinones a.
Table 1. The Paternò–Büchi reaction of aromatic with quinones a.
Molecules 29 01513 i001
Entry1a:2a (Equiv.)Photosensitizers (5 mmol%)SolventTemp. (°C)Yield (%) b
11:1-CH3CN4025
21:3-CH3CN4033
32:1-CH3CN4032
43:1-CH3CN4043
5 [c]3:1-CH3CN407
63:1Ir(ppy)3CH3CN40np [d]
73:1Ru(bpy)3Cl2·6H2OCH3CN4032
83:1Thioxanthen-9-oneCH3CN4040
93:1-CH3CN–4048
103:1-Et2O–78np
113:1-THF–78np
123:1-DCM–7874
13 [e]3:1-DCM–78np
a Reaction conditions: 1a and 2a (0.30 mmol) in the solvent (3 mL) under blue LED irradiation for 48 h. b Isolated yields. [c] Light source: 254 nm. [d] np = no product. [e] No blue LED irradiation.
Table 2. Optimization of the reaction conditions for the synthesis of diaryl ethers a.
Table 2. Optimization of the reaction conditions for the synthesis of diaryl ethers a.
Molecules 29 01513 i002
Entry1b:2a (Equiv.)Catalyst (% b)SolventTemp. (°C)Yield (%) c
13:1Cu(OTf)2 (10)CH3CN4050
2 d3:1Cu(OTf)2 (10)CH3CN40np
3 e3:1Cu(OTf)2 (10)CH3CN4023
4 f3:1Cu(OTf)2 (10)CH3CN4046
53:1Fe(OTf)3 (10)CH3CN4045
63:1Zn(OTf)2 (10)CH3CN4043
73:1Yb(OTf)3 (10)CH3CN4016
83:1Nd(OTf)3 (10)CH3CN4015
93:1Sc(OTf)3 (10)CH3CN4010
103:1Pd(OAc)2 (10)CH3CN40np
113:1AgOAc (10)CH3CN40np
123:1BF3·Et2O (10)CH3CN40np
133:1Cu(OTf)2 (10)CH3CN2553
143:1Cu(OTf)2 (10)CH3CN1044
151:1Cu(OTf)2 (10)CH3CN2528
161.5:1Cu(OTf)2 (10)CH3CN2537
172:1Cu(OTf)2 (10)CH3CN2539
181:1.5Cu(OTf)2 (10)CH3CN2539
193:1Cu(OTf)2 (20)CH3CN2565
203:1Cu(OTf)2 (20)CH3OH25np
213:1Cu(OTf)2 (20)acetone25np
223:1Cu(OTf)2 (20)Et2O25np
233:1Cu(OTf)2 (20)THF25np
243:1Cu(OTf)2 (20)DCM2545
253:1Cu(OTf)2 (20)CH3CN/
DCM		2567
26 g3:1Cu(OTf)2 (20)CH3CN/
DCM		25np
a Reaction conditions: 1b and 2a (0.30 mmol) in the solvent (3 mL) under blue LED irradiation for 48 h. b The mole ratio of 2a. c Isolated yields. d Ir(bpy)3 (5% mole of 2a) was added. e Ru(bpy)3Cl2·6H2O (5% mole of 2a) was added. f Thioxanthen-9-one (5% mole of 2a) was added. g No blue LED irradiation.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Li, W.-W.; Zhao, J.-L.; Wang, Z.-Y.; Li, P.-T.; Shi, Z.-F.; Cao, X.-P.; Liu, Q. A Paternò–Büchi Reaction of Aromatics with Quinones under Visible Light Irradiation. Molecules 2024, 29, 1513. https://doi.org/10.3390/molecules29071513

AMA Style

Li W-W, Zhao J-L, Wang Z-Y, Li P-T, Shi Z-F, Cao X-P, Liu Q. A Paternò–Büchi Reaction of Aromatics with Quinones under Visible Light Irradiation. Molecules. 2024; 29(7):1513. https://doi.org/10.3390/molecules29071513

Chicago/Turabian Style

Li, Wen-Wen, Jia-Lin Zhao, Ze-Yu Wang, Pei-Ting Li, Zi-Fa Shi, Xiao-Ping Cao, and Qiang Liu. 2024. "A Paternò–Büchi Reaction of Aromatics with Quinones under Visible Light Irradiation" Molecules 29, no. 7: 1513. https://doi.org/10.3390/molecules29071513

APA Style

Li, W. -W., Zhao, J. -L., Wang, Z. -Y., Li, P. -T., Shi, Z. -F., Cao, X. -P., & Liu, Q. (2024). A Paternò–Büchi Reaction of Aromatics with Quinones under Visible Light Irradiation. Molecules, 29(7), 1513. https://doi.org/10.3390/molecules29071513

Article Metrics

Back to TopTop